Analgesics in the United Kingdom

Abstract
Analgesics is continuing to record a strong performance in 2022, following two years of high growth due to the pandemic. The rise and spread of the Omicron variant, the administration of the third booster doses of the vaccination, and the strong return of the common cold and influenza at the end of 2021 and beginning of 2022, combined with acetaminophen shortages due to supply chain issues, triggered new waves of fear and uncertainty in the UK. This led to stockpiling behaviour by consumers, whi...

Euromonitor International's Analgesics in United Kingdom report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Analgesics in the United Kingdom

List Of Contents And Tables

ANALGESICS IN THE UNITED KINGDOM
KEY DATA FINDINGS
2022 DEVELOPMENTS
Retail sales of analgesics continue to rise amid new Omicron wave and strong return of the common cold and influenza
Demand for private label systemic analgesics increases as cost-of-living crisis squeezes consumers’ disposable incomes
NHS shortages and OTC switches boost demand for combination products
PROSPECTS AND OPPORTUNITIES
Growth of analgesics to stabilise due to maturity, low innovation, strong competition from alternatives and high private label penetration
Topical analgesics and combination products set to be strongest performers
E-commerce loses ground as consumers return to physical stores
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2017-2022
Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN THE UNITED KINGDOM
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources